bertrand knebelmann

Citée par

	Toutes	Depuis 2019
Citations	14263	5697
indice h	63	42
indice i10	122	92

1300

650

325

975

1993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202447 54 59 64 51 108 106 209 256 232 285 280 322 274 297 353 330 342 373 491 511 483 561 711 673 811 865 1008 1017 1215 1212 357

Accès public

Tout afficher

35 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Vikas P. SukhatmeEmory School of MedicineAdresse e-mail validée de emory.edu
Laurence HeidetAPHPAdresse e-mail validée de aphp.fr
Khalil EL KAROUIINSERMAdresse e-mail validée de inserm.fr
S. Ananth KarumanchiCedars-Sinai Medical Center; Beth Israel Deaconess Medical Center, Harvard Medical SchoolAdresse e-mail validée de csmc.edu
rémi salomonProfessor of medicineAdresse e-mail validée de aphp.fr
Camille CohenNéphrologie hôpital Necker, INSERM U1151Adresse e-mail validée de inserm.fr
Oliver GrossProfessor für Innere Medizin, Universitätsmedizin GöttingenAdresse e-mail validée de med.uni-goettingen.de
Karl TryggvasonProfessor, Karolinska Institute, Stockholm & Duke-NUS, SingaporeAdresse e-mail validée de tryggvason.com
Albert C OngUniversity of SheffieldAdresse e-mail validée de sheffield.ac.uk
Olivia BoyerHôpital Necker Enfants Malades, APHP, Institut Imagine, Université de Paris, FranceAdresse e-mail validée de aphp.fr
karin dahanDirecteur du Centre de Génétique de l'IPGAdresse e-mail validée de ipg.be
Matthew WatermanProfessor of Biology, Eastern Nazarene CollegeAdresse e-mail validée de enc.edu
Frances FlinterEmeritus Professor of Clinical Genetics, Guy's & St Thomas' NHS Foundation TrustAdresse e-mail validée de gstt.nhs.uk
Soumeya BEKRIProfessor of Medical Biochemistry and Molecular Biology - Rouen UniversityAdresse e-mail validée de chu-rouen.fr
Jean-Philippe JaisMCU-PH, Biostatistique et Informatique Médicale, Université Paris-DescartesAdresse e-mail validée de parisdescartes.fr
Roser Torra BalcellsFundacio PuigvertAdresse e-mail validée de fundacio-puigvert.es
Ron T. GansevoortProfessor of Internal Medicine, UMC Groningen, the NetherlandsAdresse e-mail validée de umcg.nl
Gérard FriedlanderEmeritus Professor of Physiology, Université Paris CitéAdresse e-mail validée de u-paris.fr
Alexandre KarrasMD, PhD, HEGP hospital, Paris, France, Université Paris DescartesAdresse e-mail validée de egp.aphp.fr
Michelle RheaultAssociate Professor of Pediatrics, University of MinnesotaAdresse e-mail validée de umn.edu

Suivre

bertrand knebelmann

Necker hospital, Université Paris Cité, Paris, France

Adresse e-mail validée de aphp.fr

kidney diseases


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Endostatin induces endothelial cell apoptosis M Dhanabal, R Ramchandran, MJF Waterman, H Lu, B Knebelmann, ... Journal of Biological Chemistry 274 (17), 11721-11726, 1999	995	1999
X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 11 (4), 649-657, 2000	669	2000
X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a “European Community Alport Syndrome Concerted … JP Jais, B Knebelmann, I Giatras, M De Marchi, G Rizzoni, A Renieri, ... Journal of the American Society of Nephrology 14 (10), 2603-2610, 2003	545	2003
Targeted therapy in patients with PIK3CA-related overgrowth syndrome Q Venot, T Blanc, SH Rabia, L Berteloot, S Ladraa, JP Duong, E Blanc, ... Nature 558 (7711), 540-546, 2018	463	2018
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans A Viau, K El Karoui, D Laouari, M Burtin, C Nguyen, K Mori, E Pillebout, ... The Journal of clinical investigation 120 (11), 4065-4076, 2010	428	2010
The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity D Mukhopadhyay, B Knebelmann, HT Cohen, S Ananth, VP Sukhatme Molecular and cellular biology 17 (9), 5629-5639, 1997	426	1997
Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin R Ramchandran, M Dhanabal, R Volk, MJF Waterman, M Segal, H Lu, ... Biochemical and biophysical research communications 255 (3), 735-739, 1999	378	1999
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy O Gross, C Licht, HJ Anders, B Hoppe, B Beck, B Tönshoff, B Höcker, ... Kidney international 81 (5), 494-501, 2012	373	2012
Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome A Servais, V Frémeaux-Bacchi, M Lequintrec, R Salomon, J Blouin, ... Journal of medical genetics 44 (3), 193-199, 2007	368	2007
Anti-CTLA4 antibody–induced lupus nephritis F Fadel, KE Karoui, B Knebelmann New England Journal of Medicine 361 (2), 211-212, 2009	324	2009
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney … RT Gansevoort, M Arici, T Benzing, H Birn, G Capasso, A Covic, ... Nephrology Dialysis Transplantation 31 (3), 337-348, 2016	317	2016
Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases L Heidet, S Decramer, A Pawtowski, V Moriniere, F Bandin, ... Clinical Journal of the American Society of Nephrology 5 (6), 1079-1090, 2010	307	2010
Autosomal dominant polycystic kidney disease: the changing face of clinical management ACM Ong, O Devuyst, B Knebelmann, G Walz The Lancet 385 (9981), 1993-2002, 2015	272	2015
Cyst infections in patients with autosomal dominant polycystic kidney disease M Salle, JR Zahar, JP Gru, B Knebelmann, F Fakhouri Clinical Journal of the American Society of Nephrology 4 (7), 1183-1189, 2009	270	2009
Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes C Arrondel, N Vodovar, B Knebelmann, JP Gru, MC Gubler, C Antignac, ... Journal of the American Society of Nephrology 13 (1), 65-74, 2002	238	2002
Steroid-sensitive nephrotic syndrome: from childhood to adulthood F Fakhouri, N Bocquet, P Taupin, C Presne, MF Gagnadoux, P Landais, ... American journal of kidney diseases 41 (3), 550-557, 2003	236	2003
Defects in the IFT-B component IFT172 cause Jeune and Mainzer-Saldino syndromes in humans J Halbritter, AA Bizet, M Schmidts, JD Porath, DA Braun, HY Gee, ... The American Journal of Human Genetics 93 (5), 915-925, 2013	235	2013
Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution MC Gubler, B Knebelmann, A Beziau, M Broyer, Y Pirson, F Haddoum, ... Kidney international 47 (4), 1142-1147, 1995	220	1995
Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib G Bollée, N Patey, G Cazajous, C Robert, JM Goujon, F Fakhouri, ... Nephrology Dialysis Transplantation 24 (2), 682-685, 2009	212	2009
Transforming growth factor α is a target for the von Hippel-Lindau tumor suppressor B Knebelmann, S Ananth, HT Cohen, VP Sukhatme Cancer Research 58 (2), 226-231, 1998	206	1998

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs